The Growing Sarcopenia Treatment Market is Driven by Increasing Geriatric Population
The sarcopenia treatment market involves various therapeutics and supplements that address muscle loss and weakness associated with aging. Sarcopenia occurs due to a gradual loss of skeletal muscle mass and strength. Major therapies for sarcopenia include vitamin D and calcium supplementation, protein supplementation, exercise, and testosterone replacement. The demand for sarcopenia treatment is rising due to the growing geriatric population worldwide that is more prone to sarcopenia.

In 2024, the global sarcopenia treatment market is estimated to be valued at US$ 3.47 billion and is expected to exhibit a CAGR of 9.5% over the forecast period of 2024-2031.
Key Takeaways
The demand for Sarcopenia Treatment Market Size treatments is growing due to the rising prevalence of sarcopenia among aged populations worldwide. Furthermore, increasing awareness regarding sarcopenia is driving more geriatric people towards diagnostic tests and available therapies. Global expansion of key players into emerging markets will further contribute to the growth of the sarcopenia treatment market during the forecast period.
Key players operating in the sarcopenia treatment market include Yokogawa, General Electric, Rockwell Automation, MAVERICK Technologies, Emerson, Siemens, Rudolph Technologies, Honeywell International, ABB, and Schneider Electric. These companies produce various therapeutic drugs, supplements, and medical devices for sarcopenia management.
Market Drivers
One of the major drivers of the sarcopenia treatment market is the increasing geriatric population worldwide that is more prone to sarcopenia and other age-related muscle wasting diseases. As per estimates, about 1.5 billion people are projected to be over the age of 65 by 2050 due to rising life expectancy. Since age is the most prominent risk factor for sarcopenia, the market for its treatment and management is expected to grow significantly with the global aging trend.
Get More Insights On Sarcopenia Treatment Market





